Baba Coulibaly
Overview
Explore the profile of Baba Coulibaly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Entomological drivers of uneven malaria transmission in urban lowland areas in Bouaké, Côte d'Ivoire
Dahoui M, Adou K, Coulibaly B, Niamien K, Kone A, Cornelie S, et al.
Malar J
. 2023 Jan;
22(1):34.
PMID: 36717848
Background: The use of urban lowlands for agriculture contributes to the food security of city- dwellers, but promotes malaria transmission. The objective of the study was to characterize the entomological...
2.
Fournet F, Adja A, Adou K, Dahoui M, Coulibaly B, Assouho K, et al.
Malar J
. 2022 Sep;
21(1):275.
PMID: 36171572
Background: Previous studies have revealed high malaria transmission in Bouaké, Côte d'Ivoire. The sociopolitical crisis in the country and the resulting environmental changes have raised the need to update existing...
3.
Koui T, Gnondjui A, Gbessi A, Ako A, Coulibaly B, Aka A, et al.
BMC Med Genomics
. 2022 May;
15(1):120.
PMID: 35606796
Background: Sickle cell disease (SCD) is a hemoglobin disorders that concern 300,000 newborns each year around the world. There are hemoglobin haplotypes that affect SCD clinic expression. Methods: Our goal...
4.
Gbessi E, Toure O, Gnondjui A, Koui T, Coulibaly B, Ako B, et al.
Parasite
. 2021 Sep;
28:67.
PMID: 34569928
Background: Artemisinin-based treatment in malaria patients with abnormal hemoglobin may be ineffective because of their genetic particularity, which could lead to resistance. The main purpose of this study was to...
5.
Zogo B, Soma D, Tchiekoi B, Some A, Alou L, Koffi A, et al.
Parasite
. 2019 Jul;
26:40.
PMID: 31298995
A better understanding of malaria transmission at a local scale is essential for developing and implementing effective control strategies. In the framework of a randomized controlled trial (RCT), we aimed...
6.
Toure O, Landry T, Assi S, Kone A, Gbessi E, Ako B, et al.
Infect Drug Resist
. 2018 Nov;
11:2031-2038.
PMID: 30464545
Introduction: Parasite clearance is useful to detect artemisinin resistance. The aim of this study was to investigate parasite clearance in patients treated with artesunate + amodiaquine (AS + AQ) and...
7.
Tossea S, Adji E, Coulibaly B, Ako B, Ngolo Coulibaly D, Joly P, et al.
BMC Res Notes
. 2018 Apr;
11(1):215.
PMID: 29609623
Objectives: Sickle cell anemia is due to a mutations on the betaglobin gene, inducing abnormal hemoglobin. In West Africa the main mutations lead to S or C types of hemoglobin....
8.
Toure O, Kone P, Coulibaly M, Ako B, Gbessi E, Coulibaly B, et al.
Parasit Vectors
. 2014 Nov;
7:495.
PMID: 25410760
Background: The World Health Organization (WHO) recommends for sub-Saharan Africa a package of prompt and effective case-management combined with the delivery of insecticide-treated nets (ITN) and intermittent preventive treatment during...
9.
Toure O, Assi S, NGuessan T, Adji G, Ako A, Brou M, et al.
Malar J
. 2014 Nov;
13:439.
PMID: 25409546
Background: Emergence of artemisinin resistance has raised concerns that the most potent anti-malarial drug may be under threat. Artesunate-amodiaquine (AS-AQ) and artemether-lumefantrine (AL) are, respectively, the first- and second-line treatments...